
<!DOCTYPE html>
<html>
<meta charset="UTF-8">
<head>
  <title>Topic 05 -- Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 71 - 15 Topics</title>

<style>
table {
  font-family: "Trebuchet MS", Arial, Helvetica, sans-serif;
  border-collapse: collapse;
  width: 100%;
}

td, th {
  border: 1px solid #ddd;
  padding: 8px;
}

tr:nth-child(even){background-color: #f2f2f2;}

tr:hover {background-color: #ddd;}

th {
  padding-top: 12px;
  padding-bottom: 12px;
  text-align: left;
  background-color: #0099FF;
  color: white;
}
</style>

</head>
<body>
<h2>Topic 05 -- Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 71 - 15 Topics</h2>
<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>cite ad</th>
      <th>title</th>
      <th>authors</th>
      <th>publish year</th>
      <th>publish time</th>
      <th>dataset</th>
      <th>abstract mentions covid</th>
      <th>pmcid</th>
      <th>pubmed id</th>
      <th>doi</th>
      <th>cord uid</th>
      <th>topic weight</th>
      <th>Similarity scispacy</th>
      <th>Similarity specter</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th id="dy7djsah";>1</th>
      <td>Ma_Y_2012</td>
      <td>Design Novel Dual Agonists for Treating Type-2 Diabetes by Targeting Peroxisome Proliferator-Activated Receptors with Core Hopping Approach</td>
      <td>Ma, Ying; Wang, Shu-Qing; Xu, Wei-Ren; Wang, Run-Ling; Chou, Kuo-Chen</td>
      <td>2012</td>
      <td>2012-06-07</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369836" target="_blank">PMC3369836</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/22685582.0" target="_blank">22685582.0</a></td>
      <td><a href="https://doi.org/10.1371/journal.pone.0038546" target="_blank">10.1371/journal.pone.0038546</a></td>
      <td>dy7djsah</td>
      <td>0.966258</td>
      <td></td>
      <td><a href="Topic_05.html#icwhpbpj">Liu_L_2013</a>, <a href="Topic_05.html#nd99ibso">Ahmadian_2013</a>, <a href="Topic_05.html#b3o0vtob">Lin_S_2019</a></td>
    </tr>
    <tr>
      <th id="icwhpbpj";>2</th>
      <td>Liu_L_2013</td>
      <td>Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics</td>
      <td>Liu, Lei; Ma, Ying; Wang, Run-Ling; Xu, Wei-Ren; Wang, Shu-Qing; Chou, Kuo-Chen</td>
      <td>2013</td>
      <td>2013-04-08</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623550" target="_blank">PMC3623550</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/23630413.0" target="_blank">23630413.0</a></td>
      <td><a href="https://doi.org/10.2147/dddt.s42113" target="_blank">10.2147/dddt.s42113</a></td>
      <td>icwhpbpj</td>
      <td>0.940291</td>
      <td></td>
      <td><a href="Topic_05.html#dy7djsah">Ma_Y_2012</a></td>
    </tr>
    <tr>
      <th id="1s44e2le";>3</th>
      <td>Kanasaki_2019</td>
      <td>Relevance of Autophagy Induction by Gastrointestinal Hormones: Focus on the Incretin-Based Drug Target and Glucagon</td>
      <td>Kanasaki, Keizo; Kawakita, Emi; Koya, Daisuke</td>
      <td>2019</td>
      <td>2019-05-16</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531852" target="_blank">PMC6531852</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/31156426.0" target="_blank">31156426.0</a></td>
      <td><a href="https://doi.org/10.3389/fphar.2019.00476" target="_blank">10.3389/fphar.2019.00476</a></td>
      <td>1s44e2le</td>
      <td>0.804036</td>
      <td></td>
      <td><a href="Topic_03.html#v5nw5fj6">Beckers_2017</a>, <a href="Topic_05.html#b3o0vtob">Lin_S_2019</a></td>
    </tr>
    <tr>
      <th id="ll6f6brf";>4</th>
      <td>Tieku_1992</td>
      <td>Inhibition of aminopeptidases N, A and W A re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme</td>
      <td>Tieku, Stephen; Hooper, Nigel M.</td>
      <td>1992</td>
      <td>1992-11-03</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111144" target="_blank">PMC7111144</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/1360211.0" target="_blank">1360211.0</a></td>
      <td><a href="https://doi.org/10.1016/0006-2952(92)90065-q" target="_blank">10.1016/0006-2952(92)90065-q</a></td>
      <td>ll6f6brf</td>
      <td>0.753765</td>
      <td><a href="Topic_05.html#gic43uwz">Deaton_2008</a></td>
      <td><a href="Topic_02.html#9yf08ufl">Noble_2000</a>, <a href="Topic_01.html#r8ddgdax">Danziger_2007</a></td>
    </tr>
    <tr>
      <th id="b3o0vtob";>5</th>
      <td>Lin_S_2019</td>
      <td>The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: from in silico to in vivo</td>
      <td>Lin, Shian-Ren; Chang, Chia-Hsiang; Tsai, May-Jwan; Cheng, Henrich; Chen, Jian-Chyi; Leong, Max K.; Weng, Ching-Feng</td>
      <td>2019</td>
      <td>2019-09-19</td>
      <td>NONCOMM</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753520" target="_blank">PMC6753520</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/31555430.0" target="_blank">31555430.0</a></td>
      <td><a href="https://doi.org/10.1177/2040622319875305" target="_blank">10.1177/2040622319875305</a></td>
      <td>b3o0vtob</td>
      <td>0.749421</td>
      <td><a href="Topic_05.html#1s44e2le">Kanasaki_2019</a>, <a href="Topic_05.html#8emckxv0">Mulvihill_2014</a>, <a href="Topic_05.html#8vj0t57e">Gong_2015</a></td>
      <td><a href="Topic_05.html#8emckxv0">Mulvihill_2014</a>, <a href="Topic_05.html#1s44e2le">Kanasaki_2019</a></td>
    </tr>
    <tr>
      <th id="3rukouk3";>6</th>
      <td>Zhong_2015</td>
      <td>Recent Advances in Dipeptidyl-Peptidase-4 Inhibition Therapy: Lessons from the Bench and Clinical Trials</td>
      <td>Zhong, Jixin; Gong, Quan; Goud, Aditya; Srinivasamaharaj, Srividya; Rajagopalan, Sanjay</td>
      <td>2015</td>
      <td>2015-05-14</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446505" target="_blank">PMC4446505</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/26075284.0" target="_blank">26075284.0</a></td>
      <td><a href="https://doi.org/10.1155/2015/606031" target="_blank">10.1155/2015/606031</a></td>
      <td>3rukouk3</td>
      <td>0.681258</td>
      <td><a href="Topic_05.html#8vj0t57e">Gong_2015</a></td>
      <td><a href="Topic_01.html#yycu42az">Panchapakesan_2015</a>, <a href="Topic_05.html#b3o0vtob">Lin_S_2019</a></td>
    </tr>
    <tr>
      <th id="m4paktyf";>7</th>
      <td>Yun_Y_2014</td>
      <td>Kimchi Methanol Extract and the Kimchi Active Compound, 3′-(4′-Hydroxyl-3′,5′-Dimethoxyphenyl)Propionic Acid, Downregulate CD36 in THP-1 Macrophages Stimulated by oxLDL</td>
      <td>Yun, Ye-Rang; Kim, Hyun-Ju; Song, Yeong-Ok</td>
      <td>2014</td>
      <td>2014-08-01</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126270" target="_blank">PMC4126270</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/25010893.0" target="_blank">25010893.0</a></td>
      <td><a href="https://doi.org/10.1089/jmf.2013.2943" target="_blank">10.1089/jmf.2013.2943</a></td>
      <td>m4paktyf</td>
      <td>0.598447</td>
      <td></td>
      <td></td>
    </tr>
    <tr>
      <th id="8emckxv0";>8</th>
      <td>Mulvihill_2014</td>
      <td>Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors</td>
      <td>Mulvihill, Erin E.; Drucker, Daniel J.</td>
      <td>2014</td>
      <td>2014-12-01</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108477" target="_blank">PMC7108477</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/25216328.0" target="_blank">25216328.0</a></td>
      <td><a href="https://doi.org/10.1210/er.2014-1035" target="_blank">10.1210/er.2014-1035</a></td>
      <td>8emckxv0</td>
      <td>0.578242</td>
      <td></td>
      <td><a href="Topic_05.html#b3o0vtob">Lin_S_2019</a>, <a href="Topic_03.html#v5nw5fj6">Beckers_2017</a></td>
    </tr>
    <tr>
      <th id="6ruond0m";>9</th>
      <td>Zhong_2016</td>
      <td>DPP4 Inhibition: Insights From the Bench and Recent Clinical Studies</td>
      <td>Zhong, Jixin; Kankanala, Saumya; Rajagopalan, Sanjay</td>
      <td>2016</td>
      <td>2016-10-01</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147592" target="_blank">PMC5147592</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/27472408.0" target="_blank">27472408.0</a></td>
      <td><a href="https://doi.org/10.1097/mol.0000000000000340" target="_blank">10.1097/mol.0000000000000340</a></td>
      <td>6ruond0m</td>
      <td>0.576089</td>
      <td><a href="Topic_05.html#8vj0t57e">Gong_2015</a></td>
      <td><a href="Topic_05.html#3rukouk3">Zhong_2015</a>, <a href="Topic_01.html#yycu42az">Panchapakesan_2015</a>, <a href="Topic_03.html#v5nw5fj6">Beckers_2017</a>, <a href="Topic_05.html#1s44e2le">Kanasaki_2019</a></td>
    </tr>
    <tr>
      <th id="nd99ibso";>10</th>
      <td>Ahmadian_2013</td>
      <td>PPARγ signaling and metabolism: the good, the bad and the future</td>
      <td>Ahmadian, Maryam; Suh, Jae Myoung; Hah, Nasun; Liddle, Christopher; Atkins, Annette R; Downes, Michael; Evans, Ronald M</td>
      <td>2013</td>
      <td>2013-05-01</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870016" target="_blank">PMC3870016</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/23652116.0" target="_blank">23652116.0</a></td>
      <td><a href="https://doi.org/10.1038/nm.3159" target="_blank">10.1038/nm.3159</a></td>
      <td>nd99ibso</td>
      <td>0.538172</td>
      <td></td>
      <td><a href="Topic_05.html#dy7djsah">Ma_Y_2012</a>, <a href="Topic_05.html#1s44e2le">Kanasaki_2019</a></td>
    </tr>
    <tr>
      <th id="8vj0t57e";>11</th>
      <td>Gong_2015</td>
      <td>Dpp4 inhibition as a therapeutic strategy in cardiometabolic disease: Incretin-dependent and -independent function</td>
      <td>Gong, Quan; Rajagopalan, Sanjay; Zhong, Jixin</td>
      <td>2015</td>
      <td>2015-10-15</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114201" target="_blank">PMC7114201</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/26142202.0" target="_blank">26142202.0</a></td>
      <td><a href="https://doi.org/10.1016/j.ijcard.2015.06.076" target="_blank">10.1016/j.ijcard.2015.06.076</a></td>
      <td>8vj0t57e</td>
      <td>0.527436</td>
      <td><a href="Topic_05.html#3rukouk3">Zhong_2015</a>, <a href="Topic_01.html#i1e39v9m">Zablocki_2011</a></td>
      <td><a href="Topic_05.html#3rukouk3">Zhong_2015</a>, <a href="Topic_01.html#yycu42az">Panchapakesan_2015</a>, <a href="Topic_05.html#6ruond0m">Zhong_2016</a>, <a href="Topic_05.html#1s44e2le">Kanasaki_2019</a></td>
    </tr>
    <tr>
      <th id="61t4e1eg";>12</th>
      <td>Kanasaki_2018</td>
      <td>The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin</td>
      <td>Kanasaki, Keizo</td>
      <td>2018</td>
      <td>2018-02-28</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828949" target="_blank">PMC5828949</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/29491123.0" target="_blank">29491123.0</a></td>
      <td><a href="https://doi.org/10.1042/cs20180031" target="_blank">10.1042/cs20180031</a></td>
      <td>61t4e1eg</td>
      <td>0.486677</td>
      <td><a href="Topic_05.html#psuqq87n">Shi_S_2016</a>, <a href="Topic_05.html#8vj0t57e">Gong_2015</a>, <a href="Topic_05.html#1s44e2le">Kanasaki_2019</a></td>
      <td><a href="Topic_01.html#yycu42az">Panchapakesan_2015</a>, <a href="Topic_05.html#b3o0vtob">Lin_S_2019</a></td>
    </tr>
    <tr>
      <th id="vbs6hn3a";>13</th>
      <td>Ma_Y_2020</td>
      <td>PPARγ and Its Agonists in Chronic Kidney Disease</td>
      <td>Ma, Yuhua; Shi, Manman; Wang, Yuxin; Liu, Jian</td>
      <td>2020</td>
      <td>2020-02-25</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060840" target="_blank">PMC7060840</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/32158560.0" target="_blank">32158560.0</a></td>
      <td><a href="https://doi.org/10.1155/2020/2917474" target="_blank">10.1155/2020/2917474</a></td>
      <td>vbs6hn3a</td>
      <td>0.451035</td>
      <td><a href="Topic_01.html#i1e39v9m">Zablocki_2011</a></td>
      <td><a href="Topic_01.html#yycu42az">Panchapakesan_2015</a>, <a href="Topic_10.html#2nwd4zbl">Wolke_2016</a>, <a href="Topic_03.html#v5nw5fj6">Beckers_2017</a></td>
    </tr>
    <tr>
      <th id="psuqq87n";>14</th>
      <td>Shi_S_2016</td>
      <td>Dipeptidyl peptidase-4 and kidney fibrosis in diabetes</td>
      <td>Shi, Sen; Koya, Daisuke; Kanasaki, Keizo</td>
      <td>2016</td>
      <td>2016-02-13</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752740" target="_blank">PMC4752740</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/26877767.0" target="_blank">26877767.0</a></td>
      <td><a href="https://doi.org/10.1186/s13069-016-0038-0" target="_blank">10.1186/s13069-016-0038-0</a></td>
      <td>psuqq87n</td>
      <td>0.430630</td>
      <td><a href="Topic_05.html#8vj0t57e">Gong_2015</a>, <a href="Topic_02.html#h0h6cri8">Soler_2008</a>, <a href="Topic_01.html#yycu42az">Panchapakesan_2015</a>, <a href="Topic_05.html#3rukouk3">Zhong_2015</a></td>
      <td><a href="Topic_01.html#yycu42az">Panchapakesan_2015</a>, <a href="Topic_05.html#61t4e1eg">Kanasaki_2018</a>, <a href="Topic_03.html#v5nw5fj6">Beckers_2017</a></td>
    </tr>
    <tr>
      <th id="1n7xjjd5";>15</th>
      <td>Rao_X_2019</td>
      <td>Oxidized LDL upregulates macrophage DPP4 expression via TLR4/TRIF/CD36 pathways</td>
      <td>Rao, Xiaoquan; Zhao, Shi; Braunstein, Zachary; Mao, Hong; Razavi, Michael; Duan, Lihua; Wei, Yingying; Toomey, Amelia C.; Rajagopalan, Sanjay; Zhong, Jixin</td>
      <td>2019</td>
      <td>2019-02-07</td>
      <td>None</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441950" target="_blank">PMC6441950</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/30738832.0" target="_blank">30738832.0</a></td>
      <td><a href="https://doi.org/10.1016/j.ebiom.2019.01.065" target="_blank">10.1016/j.ebiom.2019.01.065</a></td>
      <td>1n7xjjd5</td>
      <td>0.427527</td>
      <td></td>
      <td><a href="Topic_03.html#v5nw5fj6">Beckers_2017</a>, <a href="Topic_03.html#r3gfr1gk">Kondo_2018</a></td>
    </tr>
    <tr>
      <th id="3bi01dvn";>16</th>
      <td>Ramya_2020</td>
      <td>Decades-old renin inhibitors are still struggling to find a niche in antihypertensive therapy. A fleeting look at the old and the promising new molecules</td>
      <td>Ramya, Krishnappa; Suresh, Ramalingam; Kumar, Honnavalli Yogish; Kumar, B.R. Prashantha; Murthy, N.B. Sridhara</td>
      <td>2020</td>
      <td>2020-03-28</td>
      <td>PMC</td>
      <td>N</td>
      <td></td>
      <td></td>
      <td><a href="https://doi.org/10.1016/j.bmc.2020.115466" target="_blank">10.1016/j.bmc.2020.115466</a></td>
      <td>3bi01dvn</td>
      <td>0.424000</td>
      <td><a href="Topic_02.html#hui5jaiu">Zhao_2008</a>, <a href="Topic_01.html#i1e39v9m">Zablocki_2011</a>, <a href="Topic_02.html#h0h6cri8">Soler_2008</a>, <a href="Topic_01.html#4p7gboaq">Tikellis_2012</a>, <a href="Topic_01.html#sckq06ku">Jones_2008</a></td>
      <td><a href="Topic_01.html#409pz4lw">Bradford_2010</a>, <a href="Topic_01.html#3rlu77kt">Patel_2016</a>, <a href="Topic_01.html#kjdcg8nz">Sparks_2014</a>, <a href="Topic_02.html#m9tn3qu0">Lambert_2008</a></td>
    </tr>
    <tr>
      <th id="gic43uwz";>17</th>
      <td>Deaton_2008</td>
      <td>Thiol-based angiotensin-converting enzyme 2 inhibitors: P1 modifications for the exploration of the S1 subsite</td>
      <td>Deaton, David N.; Gao, Enoch N.; Graham, Kevin P.; Gross, Jeffrey W.; Miller, Aaron B.; Strelow, John M.</td>
      <td>2008</td>
      <td>2008-01-15</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126659" target="_blank">PMC7126659</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/18078750.0" target="_blank">18078750.0</a></td>
      <td><a href="https://doi.org/10.1016/j.bmcl.2007.11.048" target="_blank">10.1016/j.bmcl.2007.11.048</a></td>
      <td>gic43uwz</td>
      <td>0.384552</td>
      <td><a href="Topic_02.html#hui5jaiu">Zhao_2008</a>, <a href="Topic_01.html#4p7gboaq">Tikellis_2012</a></td>
      <td></td>
    </tr>
    <tr>
      <th id="tulmnb32";>18</th>
      <td>Schrom_2017</td>
      <td>Translation of Angiotensin-Converting Enzyme 2 upon Liver- and Lung-Targeted Delivery of Optimized Chemically Modified mRNA</td>
      <td>Schrom, Eva; Huber, Maja; Aneja, Manish; Dohmen, Christian; Emrich, Daniela; Geiger, Johannes; Hasenpusch, Günther; Herrmann-Janson, Annika; Kretzschmann, Verena; Mykhailyk, Olga; Pasewald, Tamara; Oak, Prajakta; Hilgendorff, Anne; Wohlleber, Dirk; Hoymann, Heinz-Gerd; Schaudien, Dirk; Plank, Christian; Rudolph, Carsten; Kubisch-Dohmen, Rebekka</td>
      <td>2017</td>
      <td>2017-04-13</td>
      <td>None</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423349" target="_blank">PMC5423349</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/28624211.0" target="_blank">28624211.0</a></td>
      <td><a href="https://doi.org/10.1016/j.omtn.2017.04.006" target="_blank">10.1016/j.omtn.2017.04.006</a></td>
      <td>tulmnb32</td>
      <td>0.353477</td>
      <td></td>
      <td><a href="Topic_02.html#q6e60nf8">Gembardt_2005</a>, <a href="Topic_12.html#ij7g0ynq">Xiao_2014</a></td>
    </tr>
  </tbody>
</table>
</body>
</html>
